Gastroesophageal Equipment & Supplies
10 equipment items found
Manufactured by:Marflow AG based inAdliswil, SWITZERLAND
Used for endoscopic ligation of esophageal, varices at or above gastroesophageal junction, Fits on wide range of endoscopes, Second last band light colour, Barrel with 7 bands available, Standard Band Ligator, Requires 9.5 to 11.2 mm, Endoscope diameter, Paediatric Band Ligator, Requires 8.0 to 9.5 mm, Endoscope ...
Manufactured by:Cook Medical LLC based inBloomington, INDIANA (USA)
Used to endoscopically ligate esophageal varices at or above the gastroesophageal junction or to ligate internal hemorrhoids. ...
Manufactured by:CEATEC Medizintechnik GmbH based inWurmlingen, GERMANY
The Nathanson retractor have proven to be ideal for primarily in Gastroesophageal Reflux Disease procedures, but can also be used in a wide range of laparoscopic surgeries as they support the entire liver to provide atraumatic exposure. The Holding and Positioning Arm can be also used for open surgery, enabling a better view of the operating ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
AZD 2066 activates the BDNF/trkB signaling pathway. AZD 2066 can be used in the research of neuropathic pain, major depressive disorder and gastroesophageal reflux ...
Manufactured by:Daiichi Sankyo Company Limited based inTokyo, JAPAN
ENHERTU (5.4 mg/kg) is approved in more than 50 countries for the treatment of adult patients with unresectable or metastatic HER2 positive breast cancer who have received a (or one or more) prior antiHER2-based regimen, either in the metastatic setting or in the neoadjuvant or adjuvant setting, and have developed disease recurrence during or within six months of completing therapy based on the ...
Manufactured by:Precirix based inBrussels, BELGIUM
Our lead product candidate, CAM-H2, consists of an HER2-targeting single-domain antibody linked to iodine-131. This targeted radioligand therapy is being developed for the treatment of patients with metastatic HER2-positive cancer indications, such as breast and gastric adenocarcinoma. In addition to the company’s lead program, two product candidates for undisclosed oncology targets are ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® cabazitaxel is an enhanced version of leading prostate cancer drug cabazitaxel (Jevtana®). Cabazitaxel (Jevtana®) had global sales of €536M in 2020 despite having multiple US FDA “Black Box” warnings. ...
Manufactured by:Myra & Co. based inGhaziabad, INDIA
FusionKraft range of preferred Cardio-Thoracic & Vascular Surgical Instruments is a comprehensive selection of specialized surgical essentials dealing into the management of the ailments of the organs inside the Thorax (the chest) – generally diagnosis & treatment of the conditions of the heart (involving heart & great vessels) & lungs ...
Manufactured by:HTL Biotechnology based inJavene, FRANCE
HTL is offering a new source of Chondroitin Sulfate and other derivatives, of non-animal origin. While most Chondroitin Sulfate on the market is of animal origin (bovine, pig, shark, fish, bird), HTL is developing a new source of Chondroitin Sulfate of non-animal origin, using ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
PNU-159682, a metabolite of the anthracycline Nemorubicin, is a highly potent DNA topoisomerase II inhibitor with excellent cytotoxicity. PNU-159682 acts as a more potent and tolerated ADC cytotoxin than Doxorubicin for ADC synthesis. PNU-159682 can be used in EDV-nanocell technology to overcome agent ...